Endocrinology, Diabetes & Metabolism Doctors in Fort Wayne, IN Accepting Medicare

7 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 7

Jeremy Ryan Grogg, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 311, Fort Wayne, IN 46845 Phone: 260-266-8840    Fax: 260-266-8849

David Arthur Sorg, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 700 Broadway, Fort Wayne, IN 46802 Phone: 260-425-3560    Fax: 260-425-3568

Meletios S. Karas, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 7900 W Jefferson Blvd, Suite 201, Fort Wayne, IN 46804 Phone: 260-432-2297    Fax: 260-969-7266

Dr. H Stephen Beyer, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7900 W Jefferson Blvd Ste 201, Fort Wayne, IN 46804 Phone: 260-432-2297

Leonard I Mastbaum, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 11123 Parkview Plaza Dr, Suite 202, Fort Wayne, IN 46845 Phone: 260-373-4280    Fax: 260-373-4288

Sana Hussain Qureshi, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 310, Fort Wayne, IN 46845 Phone: 260-266-8840    Fax: 260-266-8849

Jeffrey Boord, MD, MPH Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 310, Fort Wayne, IN 46845 Phone: 260-266-8840

News Archive

American Society of Hematology announces first recipients of ASH Bridge Grants

The American Society of Hematology, the world's largest professional organization dedicated to the causes and treatment of blood disorders, today announced the first recipients of the ASH Bridge Grants, a new award program designed to help hematologists continue their critical blood disease research amid severe funding reductions for the National Institutes of Health.

Study provides different characteristics of COVID-19

The Coronavirus Disease 2019 (COVID-19) pandemic has affected almost every part of the globe with millions of cases and over a million deaths.

Improved infection prevention practices could help halt spread of S. aureus in the operating room

Adherence to proven protocols for disinfecting surgeons' hands, patients' skin, and operating room surfaces could help to halt the spread of dangerous Staphylococcus aureus (S. aureus) pathogens in the operating room and beyond, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.

Takeda receives FDA approval for VELCADE sNDA to treat MM

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.

Newly identified molecular pathway could lead to new treatments for reflux, incontinence disorders

Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.

Read more Medical News

› Verified 3 days ago